HPV vaccines: Global perspectives
The discovery of HPV as the etiological factor for HPV-associated malignancies and disease has opened up several opportunities for prevention and therapy. Current commercially available HPV vaccines (Gardasil, Gardasil 9, and Cervarix) are prophylactic in nature and derived from adjuvanted L1-based...
Saved in:
Main Authors: | Gaurav Gupta (Author), Reinhard Glueck (Author), Pankaj R. Patel (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Global disparities in HPV vaccination
by: Ophira Ginsburg
Published: (2016) -
Chinese Vaccine Providers' Perspectives on the HPV Vaccine
by: Mengdi Ji BS, et al.
Published: (2020) -
Provider perspectives on multilevel barriers to HPV vaccination
by: Paige W. Lake, et al.
Published: (2019) -
A systematic review of interventions to promote HPV vaccination globally
by: Cam Escoffery, et al.
Published: (2023) -
Pediatricians' perspectives on COVID-19 and HPV vaccine hesitancy
by: Grace W. Ryan, et al.
Published: (2023)